Marpai, Inc. (MRAI): M&A transaction — Marpai closes acquisition of Maestro Health, doubling its size in self-funded TPA market

Marpai, Inc.

Acquisition closed Oct 31, 2022, doubles Marpai's customer and member count.
Maestro serves over 80 self-insured employers; combined company covers over 40,000 employees.
Maestro adds clinical care management and pharmacy cost containment saving up to 75% on specialty meds.
Integration of Maestro brand and systems expected by early 2023.
Marpai CEO expects acquisition to transform cost and outcome curves in self-funded healthcare.

item 2.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Marpai, Inc. completed an acquisition involving Maestro Health, LLC (closed 2022-10-31).

Action: acquisition
Counterparty: Maestro Health, LLC
Closing: 2022-10-31

Exact text from the filing

On October 31, 2022, Marpai, Inc. (the “Company”) consummated the previously announced acquisition (the “Acquisition”) of Maestro Health, LLC (“Maestro Health”), a Delaware limited liability company, pursuant to the terms of the Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation, and AXA S.A., a French société anonyme.

View on SEC.gov

5 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Marpai, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-020829

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.